Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States

View ORCID ProfileAsieh Golozar, View ORCID ProfileLana YH Lai, View ORCID ProfileAnthony G. Sena, View ORCID ProfileDavid Vizcaya, View ORCID ProfileLisa M. Schilling, View ORCID ProfileVojtech Huser, View ORCID ProfileFredrik Nyberg, View ORCID ProfileScott L. Duvall, Daniel R. Morales, View ORCID ProfileThamir M Alshammari, View ORCID ProfileHamed Abedtash, Waheed-Ul-Rahman Ahmed, View ORCID ProfileOsaid Alser, View ORCID ProfileHeba Alghoul, Ying Zhang, Mengchun Gong, Yin Guan, View ORCID ProfileCarlos Areia, View ORCID ProfileJitendra Jonnagaddala, View ORCID ProfileKarishma Shah, Jennifer C.E. Lane, Albert Prats-Uribe, Jose D. Posada, Nigam H. Shah, Vignesh Subbian, Lin Zhang, Maria Tereza Fernandes Abrahão, View ORCID ProfilePeter R. Rijnbeek, Seng Chan You, Paula Casajust, View ORCID ProfileElena Roel, View ORCID ProfileMartina Recalde, Sergio Fernández-Bertolín, Alan Andryc, Jason A. Thomas, View ORCID ProfileAdam B. Wilcox, Stephen Fortin, View ORCID ProfileClair Blacketer, View ORCID ProfileFrank DeFalco, Karthik Natarajan, View ORCID ProfileThomas Falconer, Matthew Spotnitz, View ORCID ProfileAnna Ostropolets, View ORCID ProfileGeorge Hripcsak, View ORCID ProfileMarc Suchard, Kristine E. Lynch, View ORCID ProfileMichael E. Matheny, Andrew Williams, View ORCID ProfileChristian Reich, View ORCID ProfileTalita Duarte-Salles, View ORCID ProfileKristin Kostka, Patrick B. Ryan, View ORCID ProfileDaniel Prieto-Alhambra
doi: https://doi.org/10.1101/2020.10.25.20218875
Asieh Golozar
1Regeneron Pharmaceutical, NY USA
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Asieh Golozar
  • For correspondence: asieh.golzoar@gmail.com
Lana YH Lai
3Division of Cancer Sciences, School of Medical Sciences, University of Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lana YH Lai
Anthony G. Sena
4Janssen R&D, Titusville NJ, USA
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony G. Sena
David Vizcaya
6Bayer Pharmaceuticals, Sant Joan Despi, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Vizcaya
Lisa M. Schilling
7Data Science to Patient Value Program, University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa M. Schilling
Vojtech Huser
8National Library of Medicine, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vojtech Huser
Fredrik Nyberg
9School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fredrik Nyberg
Scott L. Duvall
10VINCI, VA Salt Lake City Health Care System, Salt Lake City, VA, & Division of Epidemiology, University of Utah, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott L. Duvall
Daniel R. Morales
11Division of Population Health and Genomics, University of Dundee, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thamir M Alshammari
12Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thamir M Alshammari
Hamed Abedtash
13Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hamed Abedtash
Waheed-Ul-Rahman Ahmed
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
15College of Medicine and Health, University of Exeter, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osaid Alser
16Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Osaid Alser
Heba Alghoul
17Faculty of Medicine, Islamic University of Gaza, Palestine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heba Alghoul
Ying Zhang
18DHC Technologies Co. Ltd, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengchun Gong
18DHC Technologies Co. Ltd, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin Guan
18DHC Technologies Co. Ltd, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Areia
19Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Areia
Jitendra Jonnagaddala
20School of Public Health and Community Medicine, UNSW Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jitendra Jonnagaddala
Karishma Shah
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karishma Shah
Jennifer C.E. Lane
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Prats-Uribe
14Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose D. Posada
21Stanford University School of Medicine, Stanford, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigam H. Shah
21Stanford University School of Medicine, Stanford, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vignesh Subbian
22College of Engineering, The University of Arizona, Tucson, Arizona, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhang
23School of Population Medicine and Public Health, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
24Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Tereza Fernandes Abrahão
24Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter R. Rijnbeek
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter R. Rijnbeek
Seng Chan You
26Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Casajust
27Real-World Evidence, Trial Form Support, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Roel
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elena Roel
Martina Recalde
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
29Universitat Autònoma de Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martina Recalde
Sergio Fernández-Bertolín
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Andryc
4Janssen R&D, Titusville NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason A. Thomas
30Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam B. Wilcox
30Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA
31UW Medicine, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam B. Wilcox
Stephen Fortin
32Observational Health Data Analytics, Janssen Research and Development, Raritan, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clair Blacketer
4Janssen R&D, Titusville NJ, USA
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clair Blacketer
Frank DeFalco
4Janssen R&D, Titusville NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Frank DeFalco
Karthik Natarajan
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
34New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Falconer
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Falconer
Matthew Spotnitz
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Ostropolets
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Ostropolets
George Hripcsak
33Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY 10032, USA
34New York-Presbyterian Hospital, 622 W 168 St, PH20 New York, NY 10032 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for George Hripcsak
Marc Suchard
35Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Suchard
Kristine E. Lynch
10VINCI, VA Salt Lake City Health Care System, Salt Lake City, VA, & Division of Epidemiology, University of Utah, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Matheny
36VINCI, Tennessee Valley Healthcare System VA, Nashville, TN & Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael E. Matheny
Andrew Williams
37Tufts Institute for Clinical Research and Health Policy Studies, US
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Reich
38Real World Solutions, IQVIA, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Reich
Talita Duarte-Salles
28Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Talita Duarte-Salles
Kristin Kostka
38Real World Solutions, IQVIA, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristin Kostka
Patrick B. Ryan
4Janssen R&D, Titusville NJ, USA
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Prieto-Alhambra
39Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Prieto-Alhambra
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Early identification of symptoms and comorbidities most predictive of COVID-19 is critical to identify infection, guide policies to effectively contain the pandemic, and improve health systems’ response. Here, we characterised socio-demographics and comorbidity in 3,316,107persons tested and 219,072 persons tested positive for SARS-CoV-2 since January 2020, and their key health outcomes in the month following the first positive test. Routine care data from primary care electronic health records (EHR) from Spain, hospital EHR from the United States (US), and claims data from South Korea and the US were used. The majority of study participants were women aged 18-65 years old. Positive/tested ratio varied greatly geographically (2.2:100 to 31.2:100) and over time (from 50:100 in February-April to 6.8:100 in May-June). Fever, cough and dyspnoea were the most common symptoms at presentation. Between 4%-38% required admission and 1-10.5% died within a month from their first positive test. Observed disparity in testing practices led to variable baseline characteristics and outcomes, both nationally (US) and internationally. Our findings highlight the importance of large scale characterization of COVID-19 international cohorts to inform planning and resource allocation including testing as countries face a second wave.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form, with the following declarations made: DPA reports grants from Amgen, grants and other from UCB Biopharma, grants from Johnson and Johnson, outside the submitted work. DM is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from National Institute of Health Research (NIHR), and Tenovus outside the submitted work. SCY reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. AG reports personal fees from Regeneron Pharmaceuticals, outside the submitted work; and she is a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. Dr. Lane reports grants from Versus Arthritis, grants from Medical Research Council, outside the submitted work. MS reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study. HA reports personal fees from Eli Lilly and Company, outside the submitted work. AS reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. AS is a full time employee of Janssen and shareholder of Johnson & Johnson. FD reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. KK reports she is an employee of IQVIA. CR reports he is an employee of IQVIA. FN was an employee of AstraZeneca until 2019 and holds some AstraZeneca shares. SF is an employee of Janssen Research and Development, a subsidiary of Johnson and Johnson. VS reports grant funding from the National Science Foundation, Agency for Healthcare Research and Quality, and the Arizona Board of Regents outside of the submitted work. The views expressed are those of the authors and do not necessarily represent the views or policy of the Department of Veterans Affairs or the United States Government. PR reports and is employee of Janssen Research and Development and shareholder of Johnson & Johnson. No other relationships or activities that could appear to have influenced the submitted work.

Clinical Protocols

https://data.ohdsi.org/Covid19CharacterizationCharybdis/

Funding Statement

The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This research received partial support from the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), US National Institutes of Health, US Department of Veterans Affairs, Janssen Research & Development, and IQVIA. The University of Oxford received funding related to this work from the Bill & Melinda Gates Foundation (Investment ID INV-016201 and INV-019257). DPA received funding from NIHR in the form of a Senior Research Fellowship (SRF-2018-11-ST2-004). WURA reports funding from the NIHR Oxford Biomedical Research Centre (BRC), Aziz Foundation, Wolfson Foundation, and the Royal College Surgeons of England. No funders had a direct role in this study. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Clinician Scientist Award programme, NIHR, Department of Veterans Affairs or the United States Government, NHS, or the Department of Health, England. UW Medicine received a grant related to this work from the Bill & Melinda Gates Foundation (INV-016910).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the data partners received Institutional Review Board (IRB) approval or exemption. STARR-OMOP had approval from IRB Panel #8 (RB-53248) registered to Leland Stanford Junior University under the Stanford Human Research Protection Program (HRPP). The use of VA-OMOP data was reviewed by the Department of Veterans Affairs Central IRB, was determined to meet the criteria for exemption under Exemption Category 4(3) and approved for Waiver of HIPAA Authorization. The research was approved by the Columbia University Institutional Review Board as an OHDSI network study. The use of SIDIAP was approved by the Clinical Research Ethics Committee of the IDIAPJGol (project code: 20/070-PCV). The use of CPRD was approved by the Independent Scientific Advisory Committee (ISAC) (protocol number 20_059RA2). The use of IQVIA-OpenClaims was exempted from IRB approval. The CU-AMC study participation was considered exempt by the Colorado Multiple Institutional Review Board. The use of the UWM-CRD data was reviewed and approved by the University of Washington Institutional Review Board (STUDY 00010708).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Analyses were performed locally in compliance with all applicable data privacy laws. Although the underlying data is not readily available to be shared, authors contributing to this paper have direct access to the data sources used in this study. All results (e.g. aggregate statistics, not presented at a patient-level with redactions for minimum cell count) are available for public inquiry. These results are inclusive of site-identifiers by contributing data sources to enable interrogation of each contributing site. All analytic code and result sets are made available at: https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis

https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
Asieh Golozar, Lana YH Lai, Anthony G. Sena, David Vizcaya, Lisa M. Schilling, Vojtech Huser, Fredrik Nyberg, Scott L. Duvall, Daniel R. Morales, Thamir M Alshammari, Hamed Abedtash, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Ying Zhang, Mengchun Gong, Yin Guan, Carlos Areia, Jitendra Jonnagaddala, Karishma Shah, Jennifer C.E. Lane, Albert Prats-Uribe, Jose D. Posada, Nigam H. Shah, Vignesh Subbian, Lin Zhang, Maria Tereza Fernandes Abrahão, Peter R. Rijnbeek, Seng Chan You, Paula Casajust, Elena Roel, Martina Recalde, Sergio Fernández-Bertolín, Alan Andryc, Jason A. Thomas, Adam B. Wilcox, Stephen Fortin, Clair Blacketer, Frank DeFalco, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, George Hripcsak, Marc Suchard, Kristine E. Lynch, Michael E. Matheny, Andrew Williams, Christian Reich, Talita Duarte-Salles, Kristin Kostka, Patrick B. Ryan, Daniel Prieto-Alhambra
medRxiv 2020.10.25.20218875; doi: https://doi.org/10.1101/2020.10.25.20218875
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
Asieh Golozar, Lana YH Lai, Anthony G. Sena, David Vizcaya, Lisa M. Schilling, Vojtech Huser, Fredrik Nyberg, Scott L. Duvall, Daniel R. Morales, Thamir M Alshammari, Hamed Abedtash, Waheed-Ul-Rahman Ahmed, Osaid Alser, Heba Alghoul, Ying Zhang, Mengchun Gong, Yin Guan, Carlos Areia, Jitendra Jonnagaddala, Karishma Shah, Jennifer C.E. Lane, Albert Prats-Uribe, Jose D. Posada, Nigam H. Shah, Vignesh Subbian, Lin Zhang, Maria Tereza Fernandes Abrahão, Peter R. Rijnbeek, Seng Chan You, Paula Casajust, Elena Roel, Martina Recalde, Sergio Fernández-Bertolín, Alan Andryc, Jason A. Thomas, Adam B. Wilcox, Stephen Fortin, Clair Blacketer, Frank DeFalco, Karthik Natarajan, Thomas Falconer, Matthew Spotnitz, Anna Ostropolets, George Hripcsak, Marc Suchard, Kristine E. Lynch, Michael E. Matheny, Andrew Williams, Christian Reich, Talita Duarte-Salles, Kristin Kostka, Patrick B. Ryan, Daniel Prieto-Alhambra
medRxiv 2020.10.25.20218875; doi: https://doi.org/10.1101/2020.10.25.20218875

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8557)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10292)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (249)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (166)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)